blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2397144

EP2397144 - Use of isoacteoside in preventing or treating amyloid beta peptide-associated diseases or conditions, and method for inhibiting formation, accumulation or aggregation of amyloid beta peptides [Right-click to bookmark this link]
Former [2011/51]Use of Isoacteoside in Preventing or Treating Amyloid Beta Peptide-Associated Diseases or Conditions, and Method for Inhibiting Formation, Accumulation or Aggregation of Amyloid Beta Peptides
[2014/35]
StatusNo opposition filed within time limit
Status updated on  06.11.2015
Database last updated on 02.11.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Sinphar Tian-li Pharmaceutical Co., Ltd. (Hangzhou)
No. 599 Hongfeng Road Yuhang Economic Development Zone Hangzhou
Zhejiang 311100 / CN
[2011/51]
Inventor(s)01 / Lin, Hang-Ching
3F.-2, No. 49, Shueiyuan Rd., Jhongjheng District
Taipei City / TW
02 / Tang, Jing-Jing
No. 84, Chung Shan Village, Tung-Shan Shine
I Lan / TW
03 / Su, Muh-Hwan
No. 84, Chung Shan Village, Tung-Shan Shine
I Lan / TW
04 / Huang, Young-Ming
No. 84, Chung Shan Village, Tung-Shan Shine
I Lan / TW
 [2011/51]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[N/P]
Former [2015/01]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2011/51]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Application number, filing date11170127.216.06.2011
[2011/51]
Priority number, dateUS20100355169P16.06.2010         Original published format: US 355169 P
[2011/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2397144
Date:21.12.2011
Language:EN
[2011/51]
Type: B1 Patent specification 
No.:EP2397144
Date:31.12.2014
Language:EN
[2015/01]
Search report(s)(Supplementary) European search report - dispatched on:EP22.08.2011
ClassificationIPC:A61K31/7042, A61K36/64, A61K9/00, A61K9/70, A61K36/00, A61K8/60, A61Q19/00, A61P25/28
[2014/32]
CPC:
A61K31/7042 (EP,KR,US); A61K31/7028 (KR); A61K31/7032 (CN);
A61K36/64 (EP,KR,US); A61K8/602 (EP,KR,US); A61P21/00 (EP);
A61P25/00 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P9/00 (EP); A61Q19/00 (EP,KR,US) (-)
Former IPC [2011/51]A61K31/7042, A61K9/00, A61K9/70, A61K36/00, A61K8/60, A61Q19/00, A61P25/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2011/51]
TitleGerman:Verwendung von Isoacteosid bei der Vorbeugung und Behandlung von Krankheiten und Störungen im Zusammenhang mit Amyloid-beta-Peptiden sowie Verfahren zur Hemmung der Bildung, Ansammlung und Anhäufung von Amyloid-beta-Peptiden[2011/51]
English:Use of isoacteoside in preventing or treating amyloid beta peptide-associated diseases or conditions, and method for inhibiting formation, accumulation or aggregation of amyloid beta peptides[2014/35]
French:Utilisation d'un isoactéoside pour la prévention ou le traitement de maladies et troubles liés au peptide d'amyloïde bêta et procédé pour inhiber la formation, l'accumulation ou l'agrégation de peptides d'amyloïde bêta[2011/51]
Former [2011/51]Use of Isoacteoside in Preventing or Treating Amyloid Beta Peptide-Associated Diseases or Conditions, and Method for Inhibiting Formation, Accumulation or Aggregation of Amyloid Beta Peptides
Examination procedure21.06.2012Amendment by applicant (claims and/or description)
21.06.2012Examination requested  [2012/32]
17.02.2014Despatch of a communication from the examining division (Time limit: M04)
25.06.2014Reply to a communication from the examining division
01.08.2014Communication of intention to grant the patent
19.11.2014Fee for grant paid
19.11.2014Fee for publishing/printing paid
19.11.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.02.2014
Opposition(s)01.10.2015No opposition filed within time limit [2015/50]
Fees paidRenewal fee
27.06.2013Renewal fee patent year 03
27.06.2014Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.06.2011
AL31.12.2014
AT31.12.2014
BG31.12.2014
CY31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
MK31.12.2014
MT31.12.2014
NL31.12.2014
PL31.12.2014
PT31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
SM31.12.2014
TR31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IE16.06.2015
LU16.06.2015
[2018/46]
Former [2018/37]HU16.06.2011
AT31.12.2014
BG31.12.2014
CY31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
MK31.12.2014
MT31.12.2014
NL31.12.2014
PL31.12.2014
PT31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
SM31.12.2014
TR31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IE16.06.2015
LU16.06.2015
Former [2018/31]HU16.06.2011
AT31.12.2014
BG31.12.2014
CY31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
MK31.12.2014
MT31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
SM31.12.2014
TR31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IE16.06.2015
LU16.06.2015
Former [2017/38]HU16.06.2011
AT31.12.2014
BG31.12.2014
CY31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
MT31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
SM31.12.2014
TR31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IE16.06.2015
LU16.06.2015
Former [2017/03]AT31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
MT31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IE16.06.2015
LU16.06.2015
Former [2016/21]AT31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IE16.06.2015
LU16.06.2015
Former [2016/20]AT31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IE16.06.2015
IT16.06.2015
LU16.06.2015
Former [2016/11]AT31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SI31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IT16.06.2015
LU16.06.2015
Former [2016/09]AT31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
MC31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IT16.06.2015
Former [2016/08]AT31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
IT16.06.2015
Former [2015/49]AT31.12.2014
CZ31.12.2014
DK31.12.2014
EE31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
Former [2015/38]AT31.12.2014
CZ31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
IS30.04.2015
Former [2015/37]CZ31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
NL31.12.2014
PL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
SK31.12.2014
NO31.03.2015
GR01.04.2015
Former [2015/36]CZ31.12.2014
ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
NL31.12.2014
RO31.12.2014
RS31.12.2014
SE31.12.2014
NO31.03.2015
GR01.04.2015
Former [2015/33]ES31.12.2014
FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
NL31.12.2014
RS31.12.2014
SE31.12.2014
NO31.03.2015
GR01.04.2015
Former [2015/29]FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
NL31.12.2014
RS31.12.2014
SE31.12.2014
NO31.03.2015
GR01.04.2015
Former [2015/24]FI31.12.2014
HR31.12.2014
LT31.12.2014
LV31.12.2014
RS31.12.2014
SE31.12.2014
NO31.03.2015
GR01.04.2015
Former [2015/23]FI31.12.2014
LT31.12.2014
NO31.03.2015
Former [2015/21]LT31.12.2014
NO31.03.2015
Former [2015/20]LT31.12.2014
Documents cited:Search[X]JP2009196905  ;
 [X]JP2007191416  ;
 KR20040064830  [ ] (ELCOM SCIENCE CO LTD);
 [XD]US2004162246  (TU PENGFEI [CN], et al) [XD] 1-12 * paragraphs [0001] - [0009] - [0 18] , [0 22] *;
 [I]WO2004014410  (KYUNG HEE UNIVERSITY [KR], et al) [I] 1-12 * page 1, lines 8-10 * * page 3, lines 23-34 * * page 4, lines 1-20 * * page 5, lines 17-18, 29-30 *;
 CN1857519  [ ] (UNIV CHINA OCEANOLOGY [CN]);
 [I]CN101703125  ;
 [I]JP2006312594  ;
 [X]  - LIU FENG-XIA ET AL, "The effects of glycosides of cistanche on learning and memory in beta-amyloid peptide induced Alzheimers disease in mice and its possible mechanism", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200605), Database accession no. PREV200600523442, XP002654644 [X] 1-12 * abstract *
    [ ] - ZHONGGUO YAOLIXUE TONGBAO, (200605), vol. 22, no. 5, ISSN 1001-1978, pages 595 - 599
 [X]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2009, no. 61, Database accession no. 2009-N27690, XP002654645 & JP2009196905 A 20090903 (EISHIN SHOJI KK) [X] 1-12 * abstract *
 [X]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2007, no. 69, Database accession no. 2007-731327, XP002654646 & JP2007191416 A 20070802 (EISHIN SHOJI KK) [X] 1-12 * abstract *
 [X]  - EPODOC, EUROPEAN PATENT OFFICE, THE HAGUE, NL, (20040721), XP002654647 [X] 1-4,7,9-11 * abstract *
 [I]  - LI ET AL, "Pedicularioside A from Buddleia lindleyana inhibits cell death induced by 1-methyl-4-phenylpyridinium ions (MPP<+>) in primary cultures of rat mesencephalic neurons", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, (20071030), vol. 579, no. 1-3, doi:10.1016/J.EJPHAR.2007.10.052, ISSN 0014-2999, pages 134 - 140, XP022410154 [I] 1-12 * abstract * * page 135, column 1, paragraph 1; figure 1 * * page 137, column 1, paragraph 4; table 1 * * page 139, column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/j.ejphar.2007.10.052
 [I]  - WANG H ET AL, "Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 1283, ISSN 0006-8993, (20090804), pages 139 - 147, (20090609), XP026350245 [I] 1-12 * the whole document *
 [I]  - JIANG Y ET AL, "Analysis of chemical constituents in Cistanche species", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, vol. 1216, no. 11, doi:10.1016/J.CHROMA.2008.07.031, ISSN 0021-9673, (20090313), pages 1970 - 1979, (20080718), XP025992515 [I] 1-12 * abstract * * page 1971, column 2, paragraph 4 - page 1972, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/j.chroma.2008.07.031
 [I]  - EPODOC, EUROPEAN PATENT OFFICE, THE HAGUE, NL, (20061108), XP002654745 [I] 1-12 * abstract *
 [I]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2010, no. 48, Database accession no. 2010-F56787, XP002654746 & CN101703125 A 20100512 (XINJIANG ECOLOGY & GEOGRAPHY INST CHINES) [I] 1-12 * abstract *
 [I]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2007, no. 03, Database accession no. 2007-021459, XP002654747 & JP2006312594 A 20061116 (TAISHO PHARM CO LTD) [I] 1-12 * abstract *
 [I]  - LI X -L ET AL, "Effects of fufang jinsiwei versus placebo, saline and Aricept on the expression of protein 95 in post-synapse dense area of brain tissue in rats with Alzheimer disease", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20050507), Database accession no. EMB-2005502417, XP002654748 [I] 1-12 * abstract *
    [ ] - CHINESE JOURNAL OF CLINICAL REHABILITATION 20050507 CN, (20050507), vol. 9, no. 17, ISSN 1671-5926, pages 139 - 141
 [I]  - ADAMS ET AL, "Plants traditionally used in age related brain disorders-A survey of ethnobotanical literature", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, (20070925), vol. 113, no. 3, doi:10.1016/J.JEP.2007.07.016, ISSN 0378-8741, pages 363 - 381, XP022230985 [I] 1-12 * page 372, column 1, paragraph 4 *

DOI:   http://dx.doi.org/10.1016/j.jep.2007.07.016
by applicantUS7087252
    - CLINICAL NEUROLOGY AND NEUROSURGERY, (1990), vol. 92, pages 305 - 310
    - J. NEUROPATH. EXP. NEURO., (2002), vol. 61, pages 282 - 293
    - NEUROLOGY, (2006), vol. 66, pages 65 - 68
    - NEUROREPORT, (2002), vol. 13-5, pages 719 - 723
    - EXPERIMENTAL EYE RESEARCH, (2004), vol. 78, pages 243 - 256
    - PICK'S DISEASE (NEUROSCIENCE LETTERS, (1994), vol. 171, pages 63 - 66
    - PHARMACOLOGY & THERAPEUTICS, (2005), vol. 108, page 131
    - NABESHIMA ET AL., NEUROSCIENCE LETTERS, (1994), vol. 170, pages 63 - 66
    - BRITISH JOURNAL OF PHARMACOLOGY, (1999), vol. 126, pages 235 - 244
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.